02/17/2025
11:15 PM | Cara Therapeutics (Filer)
| Form EFFECT | |
02/14/2025
4:13 PM | Cara Therapeutics (Filer)
| Form 424B3 | |
02/14/2025
5:01 AM | Cara Therapeutics (Filer)
| Form S-4/A | |
02/06/2025
6:15 PM | Cara Therapeutics (Issuer)
Posner Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/27/2025
5:19 AM | Cara Therapeutics (Filer)
| Form S-4/A | |
01/21/2025
7:50 AM | Cara Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/21/2025
7:53 AM | Cara Therapeutics (Subject)
| Form 425 | |
01/17/2025
3:43 PM | Cara Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/17/2025
3:44 PM | Cara Therapeutics (Subject)
| Form 425 | |
12/30/2024
3:02 PM | Cara Therapeutics (Subject)
| Form 425 | |
12/30/2024
3:01 PM | Cara Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Get the Latest News and Ratings for CARA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Cara Therapeutics and its competitors with MarketBeat's FREE daily newsletter. |
12/18/2024
4:10 PM | Cara Therapeutics (Subject)
Vifor Ltd (0001675217) (Filed by)
| Form SCHEDULE 13D/A | |
12/18/2024
3:26 PM | Cara Therapeutics (Filer)
| Form S-4
Registration statement under Securities Act of 1933 | |
12/18/2024
6:23 AM | Cara Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/18/2024
6:25 AM | Cara Therapeutics (Subject)
| Form 425 | |
11/22/2024
3:09 PM | Cara Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/06/2024
3:51 PM | Cara Therapeutics (Issuer)
Posner Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/30/2024
3:21 PM | Cara Therapeutics (Subject)
Vifor Ltd (0001675217) (Filed by)
| Form SC 13D | |
08/01/2024
3:15 PM | Cara Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/08/2024
3:32 PM | BlackRock Inc. (Filed by)
Cara Therapeutics (Subject)
| Form SC 13G/A | |
06/12/2024
4:12 PM | Cara Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/06/2024
3:26 PM | Cara Therapeutics (Issuer)
von Moltke Lisa (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/06/2024
3:28 PM | Boudreau Helen M (Reporting)
Cara Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/22/2024
3:07 PM | Cara Therapeutics (Filer)
| Form ARS | |
04/22/2024
3:08 PM | Cara Therapeutics (Filer)
| Form DEFA14A | |
04/12/2024
3:15 PM | Cara Therapeutics (Filer)
Cara Therapeutics (Filer)
| Form PRE 14A | |
04/09/2024
3:21 PM | Cara Therapeutics (Issuer)
Terrillion Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/09/2024
3:22 PM | Cara Therapeutics (Issuer)
Goncalves Joana (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
3:16 PM | Cara Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/04/2024
3:24 PM | Cara Therapeutics (Issuer)
Terrillion Scott (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
3:13 PM | Cara Therapeutics (Issuer)
Goncalves Joana (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
3:19 PM | Cara Therapeutics (Issuer)
Posner Christopher (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
